|
MedChemExpress
β lapachone ![]() β Lapachone, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/%CE%B2-lapachone/%CE%B2-Lapachone/pmc11882534-25-0-4 Average 94 stars, based on 1 article reviews
β lapachone - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
u k β lapachone ![]() U K β Lapachone, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/%CE%B2-lapachone/%CE%B2-Lapachone/pmc07772575-35-24-33 Average 91 stars, based on 1 article reviews
u k β lapachone - by Bioz Stars,
2026-11
91/100 stars
|
Buy from Supplier |
|
Selleck Chemicals
beta lapachone ![]() Beta Lapachone, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/%CE%B2-lapachone/Beta-Lapachone/pmc08591123-89-0-6 Average 93 stars, based on 1 article reviews
beta lapachone - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Nanotherapeutics
beta-lapachone micellar nanotherapeutics ![]() Beta Lapachone Micellar Nanotherapeutics, supplied by Nanotherapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/%CE%B2-lapachone/beta+lapachone+micellar+nanotherapeutics/pm26785610-536-20-24 Average 90 stars, based on 1 article reviews
beta-lapachone micellar nanotherapeutics - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Ciba Geigy
β-lapachone ![]() β Lapachone, supplied by Ciba Geigy, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/%CE%B2-lapachone/%CE%B2+lapachone/pmc04807624-38-18-21 Average 90 stars, based on 1 article reviews
β-lapachone - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Macklin Inc
β-lapachone ![]() β Lapachone, supplied by Macklin Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/%CE%B2-lapachone/%CE%B2+lapachone/pmc11626936__thnov14p7349s1-8-40-62 Average 90 stars, based on 1 article reviews
β-lapachone - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Biomol GmbH
β-lapachone ![]() β Lapachone, supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/%CE%B2-lapachone/%CE%B2+lapachone/pm20395409-51-37-39 Average 90 stars, based on 1 article reviews
β-lapachone - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Enzo Biochem
β-lapachone ![]() β Lapachone, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/%CE%B2-lapachone/%CE%B2+lapachone/pmc03962598-61-47-50 Average 90 stars, based on 1 article reviews
β-lapachone - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Southeast Pharmaceuticals Inc
β-lapachone ![]() β Lapachone, supplied by Southeast Pharmaceuticals Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/%CE%B2-lapachone/pmc04333567-36-0-4 Average 90 stars, based on 1 article reviews
β-lapachone - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Shanghai Yuanye Biochemicals
β-lapachone ![]() β Lapachone, supplied by Shanghai Yuanye Biochemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/%CE%B2-lapachone/%CE%B2+lapachone/10__1016_slash_j__snb__2020__128557-49-24-39 Average 90 stars, based on 1 article reviews
β-lapachone - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
NanoCarrier Co
β-lapachone micelles ![]() β Lapachone Micelles, supplied by NanoCarrier Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/%CE%B2-lapachone/%CE%B2+lapachone+micelles/pmc09315356-537-13-20 Average 90 stars, based on 1 article reviews
β-lapachone micelles - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Pharmatech
β-lapachone ![]() β Lapachone, supplied by Pharmatech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/%CE%B2-lapachone/%CE%B2+lapachone/pmc06138237__SC___009___C8SC02634C___s001-249-15-28 Average 90 stars, based on 1 article reviews
β-lapachone - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Frontiers in Pharmacology
Article Title: β-lapachone suppresses carcinogenesis of cervical cancer via interaction with AKT1
doi: 10.3389/fphar.2025.1509568
Figure Lengend Snippet: β-Lapachone inhibits the proliferation of cervical cancer cells. (A) Chemical structures of β-lapachone. (B) Expression of NQO1 in cervical cancer and normal tissues were analyzed by GEPIA database. (C) NQO1 protein levels in cancer cell lines and normal cells were detected by Western blot. (D) Cell viability was detected by MTT assay after treatment of cervical cancer cells with different concentrations of β-lapachone. (E) The expression of NQO1 protein in SiHa and C33a cells treated with β-lapachone for 24 h. (F) The effect of β-lapachone on cell proliferation was detected by colony formation assay. Error bars represent the means ± SD of three independent experiments. * P < 0.05, ** P < 0.01 vs. 0 μM β-lapachone group.
Article Snippet:
Techniques: Expressing, Western Blot, MTT Assay, Colony Assay
Journal: Frontiers in Pharmacology
Article Title: β-lapachone suppresses carcinogenesis of cervical cancer via interaction with AKT1
doi: 10.3389/fphar.2025.1509568
Figure Lengend Snippet: β-Lapachone attenuated cervical cancer cell migration, invasion, EMT and angiogenesis. (A, B) Wound healing assay was used to reflect the migration ability of SiHa and C33a cells after treatment with the indicated concentrations (0–6 µM) of β-lapachone. (C, D) Transwell assay was used to detect the effect of the indicated concentrations of β-lapachone treatment on the migration and invasion ability of CC cells. (E, F) Cells were treated with β-lapachone (0–6 µM) for 24 h, and protein levels of E-cadherin, Vimentin, and Snail were analyzed by Western blot. (G) The supernatant from cells treated with β-lapachone (0–6 μM) for 24 h was collected for the tube formation assay. (H) After treating cells with β-lapachone (0–6 µM), VEGF protein expression was detected by Western blot. Error bars represent the means ± SD of three independent experiments. * P < 0.05, ** P < 0.01 vs. 0 μM β-lapachone group.
Article Snippet:
Techniques: Migration, Wound Healing Assay, Transwell Assay, Western Blot, Tube Formation Assay, Expressing
Journal: Frontiers in Pharmacology
Article Title: β-lapachone suppresses carcinogenesis of cervical cancer via interaction with AKT1
doi: 10.3389/fphar.2025.1509568
Figure Lengend Snippet: β-lapachone regulates glucose metabolism reprogramming in cervical cancer cells. (A, B) SiHa and C33a cells were treated with the indicated concentrations of β-lapachone (0–6 µM) for 24 h. Relative levels of ATP, Lactate and Glucose were determined. (C, D) After treating cells with β-lapachone (0–6 µM), PKM2 and G6PC protein expression was detected by Western blot. Error bars represent the means ± SD of three independent experiments. * P < 0.05, ** P < 0.01 vs. 0 μM β-lapachone group.
Article Snippet:
Techniques: Expressing, Western Blot
Journal: Frontiers in Pharmacology
Article Title: β-lapachone suppresses carcinogenesis of cervical cancer via interaction with AKT1
doi: 10.3389/fphar.2025.1509568
Figure Lengend Snippet: β-lapachone inhibits cervical cancer progression and metastasis via the PI3K/AKT/mTOR signaling pathway. (A) Prediction of β-lapachone related target genes in cervical cancer. (B) KEGG pathway enrichment analysis. (C) After treating cells with β-lapachone (0–6 µM), p-AKT/t-AKT, p-mTOR/t-mTOR protein expression was detected by Western blot. (D) The expression of proteins related to the PI3K/AKT/mTOR pathway and EMT process in CC cells was detected by Western blot after treating with β-lapachone and the pathway activator 740 Y-P. Error bars represent the means ± SD of three independent experiments. * P < 0.05, ** P < 0.01 vs. DMSO group, # P < 0.05, ## P < 0.01 vs. β-lapachone group.
Article Snippet:
Techniques: Expressing, Western Blot
Journal: Frontiers in Pharmacology
Article Title: β-lapachone suppresses carcinogenesis of cervical cancer via interaction with AKT1
doi: 10.3389/fphar.2025.1509568
Figure Lengend Snippet: β-lapachone inhibits glucose metabolism and EMT process in CC cells by targeting AKT1. (A) Docking analysis for predicting the binding mode of β-lapachone to AKT1. (B) Western blot analysis of AKT1 in CC cells transfected with siRNA-control, siRNA-AKT1-1、siRNA-AKT1-2 and siRNA-AKT1-3. (C, D) CC cells with AKT1 knockdown were treated with β-lapachone for 24 h, and protein expression levels were analyzed by Western blot. * P < 0.05, ** P < 0.01 vs. β-lapachone group.
Article Snippet:
Techniques: Binding Assay, Western Blot, Transfection, Control, Knockdown, Expressing
Journal: Frontiers in Pharmacology
Article Title: β-lapachone suppresses carcinogenesis of cervical cancer via interaction with AKT1
doi: 10.3389/fphar.2025.1509568
Figure Lengend Snippet: β-Lapachone inhibits tumor growth in vivo . (A) Images of subcutaneous xenograft tumors in the treatment group β-lapachone and control group. (B) Weight statistics of subcutaneous xenograft tumors in the treatment and control groups. (C) Growth volume statistics of subcutaneous xenograft tumors in the treatment and control groups during treatment with β-lapachone. (D) Representative immunohistochemical staining images of Ki67 expression in grafted tumor tissues from various groups of mice; Representative H&E stained images of liver, kidney and lung tissues from each group of mice. Scale bar: 50 μm * P < 0.05, ** P < 0.01.
Article Snippet:
Techniques: In Vivo, Control, Immunohistochemical staining, Staining, Expressing
Journal: Frontiers in Pharmacology
Article Title: β-lapachone suppresses carcinogenesis of cervical cancer via interaction with AKT1
doi: 10.3389/fphar.2025.1509568
Figure Lengend Snippet: Schematic illustration of the mechanisms by which β-lapachone regulates glucose metabolism, EMT process and angiogenesis in cervical cancer through the PI3K/AKT/mTOR signaling pathway.
Article Snippet:
Techniques:
Journal: Cancer research
Article Title: β -Lapachone-mediated Apoptosis in Human Promyelocytic Leukemia (HL-60) and Human Prostate Cancer Cells: A p53-independent Response
doi:
Figure Lengend Snippet: β-Lapachone inhibits the catalytic activity of Topo). A, Topo I (3.0 units) was incubated with camptothecin or various concentrations of β-lapachone for 10 min at 37°C. p36B4 supercoiled plasmid DNA (1.5 μg) was then added to initiate DNA unwinding reactions. Topo I DNA unwinding activity was measured as described (14, 15). B, Topo I DNA unwinding assays were repeated as in (A), except that camptothecin or various concentrations of β-lapachone were incubated with DNA for 5 min at 37°C. Reactions were then initiated by adding 3.0 units of purified human placental Topo I (TopoGEN). β-Lapachone was an effective inhibitor only when incubated with the enzyme prior to adding DNA to initiate the reactions. Form I, supercoiled DNA substrate; Form II, open circular DNA product; R, DNA reaction intermediates.
Article Snippet: Thus, not only were freshly synthesized and dissolved samples required to observe the effects described below, but the
Techniques: Activity Assay, Incubation, Plasmid Preparation, Purification
Journal: Cancer research
Article Title: β -Lapachone-mediated Apoptosis in Human Promyelocytic Leukemia (HL-60) and Human Prostate Cancer Cells: A p53-independent Response
doi:
Figure Lengend Snippet: Dow-response and temporal kinetics of apoptosis induction in HL-60 cells by β-lapachone. In A and B, log-phase human HL-60 cells were exposed to 5.0 μM β-lapachone or camptothecin and then assayed for apoptotic responses in the first 4 h. A, apoptotic DNA laddering by 1.8% agarose gel electrophoresis; B, cell cycle and apoptotic responses by flow cytometry. Treatment conditions were: a, control; b–e, β-lapachone; or f, camptothecin. In C and D, log-phase HL-60 cells were treated with increasing concentrations of β-lapachone (0.05–5.0 μM) or camptothecin (5.0 μM) for 4 h, and apoptotic responses were noted by 1.8% agarose gel electrophoresis (C) in D and flow cytometry (D) as described in “Materials and Methods.” β-Lapachone induced a G0/G1 block and caused apoptosis in a concentration-dependent fashion. Treatment conditions (4 h at 37°C) in D were: a, 0.25% DMSO-treated control; b, 0.5 μM β-lapachone; c, 1.0 μM β-lapachone; d, 5.0 μM β-lapachone; and e, 5.0 μM camptothecin. In B and D, flow cytometric analyses were generated by computer as described in “Materials and Methods.” Shaded areas, G0/G1 and G2/M cell populations; parallel lines, S-phase cells. Single line tracings are the actual flow cytometric data.
Article Snippet: Thus, not only were freshly synthesized and dissolved samples required to observe the effects described below, but the
Techniques: DNA Laddering, Agarose Gel Electrophoresis, Flow Cytometry, Control, Blocking Assay, Concentration Assay, Generated
Journal: Cancer research
Article Title: β -Lapachone-mediated Apoptosis in Human Promyelocytic Leukemia (HL-60) and Human Prostate Cancer Cells: A p53-independent Response
doi:
Figure Lengend Snippet: β-Lapachone causes G0/G1 arrest and subsequent apoptosis in human prostate cancer cells. Log-phase PC-3, DU-145, or LNCaP cells were treated with or without (0.25% DMSO control) 1.0 or 5.0 μM β-lapachone. At various times, cells were analyzed for apoptotic cell populations and for alterations in cell cycle stages by flow cytometry. Shown are DU-145 (mutant p53 prostate cancer) cells, untreated (A) or treated with 1.0 μM(B) or 5.0 μM β-lapachone for 4 h, washed, and examined 13 h (C) or 24 h (D) later. β-Lapachone-treated cells arrested at G0/G1 and underwent apoptosis. Cells treated in a similar fashion with 5.0 μM topotecan (or camptothecin) for 4 h arrested in S but also demonstrated significant apoptotic responses (data not shown). Similar results to that of DU-145 (mutant p53) cells (Fig. 3) were obtained with PC-3 (null p53) and LNCaP (wild-type p53) cells (Table 1).
Article Snippet: Thus, not only were freshly synthesized and dissolved samples required to observe the effects described below, but the
Techniques: Control, Flow Cytometry, Mutagenesis